dpp4 vs sglt2 vs glp-1 of the effects of DPP-4 and inhibitors on metabolic parameters Comparison of GLP-1 receptor agonists

At Be Well Berlin , we treat obesity as the complex biological condition it is addressing hormones, metabolism, mental health, sleep, and medication side effects

Drugs that may be excluded from coverage under the MDRP include drugs used for: a) anorexia, weight loss, or weight gain, b) promoting fertility, c) cosmetic purposes or hair growth, d) symptomatic relief of cough and colds, e) prescription vitamins and mineral products except prenatal vitamins and fluoride preparations , f) nonprescription drugs, g) a manufacturers covered outpatient drug in which tests and monitoring services have to be purchased from that manufacturer, h) sexual or erectile dysfunction unless used to treat a condition

To assess this, randomized trials typically evaluate the primary outcome of major adverse cardiovascular events (MACE), which includes cardiovascular death, non-fatal stroke, and non-fatal myocardial infarction (MI)

These medications, originally developed for type 2 diabetes management, produce substantial weight loss partly through central nervous system mechanisms, though most glucose-lowering effects occur through peripheral actions